Walker Friday, 01/12/18 12:34:38 PM Re: RIGATONI post# 318318 Post # of 326738 SHMN - Some great DD/Info Here: DD_dempsey Member Level Sunday, 12/17/17 07:50:41 AM Re: justanotherfigment post# 12909 Post # 13008 of 13744 Go WHY $SHMN -Why Now? Pharma and Blockchain/Smart Contracts A little DD Review here can't hurt : It was pretty apparent to me that there was an error in one of the latest press release thorugh GlobeNewswire that did catch most by surprise and sure - one can argue it led to the increase in Pps. The problem was - there was no actual press release that followed. So the correction that was issued today was actually perfect. It clearly states it's in the prelim stages of determining how to integrate the Pharma and nutraceutical markets with a Bitcoin/ICO type currency or exchange as a means for sale, exchange etc. I have confirmed that to be the case. That does clear it up for me as one can only assume they were not ready YET to put that press release in the queue. Hmmmm. Perhaps we accidentally got a glimpse of what's set to come? What I do like - is a management that speaks to its shareholders and clarifies. They are NEGOTIATING To enter the Bitcoin ICO marketplace - via venture. That was what they are implying here below. That's a very good sign as adding the element that they are STILL REALLY LOOKING INTO BITCOIN IS HUGE. They didn't deny that they were looking of that they were trying to find suit sale partne for synergy. They actually reconfirmed it in the press below. https://www.sohm.com/2017/12/07/sohm-inc-announce-share-holder-update-corrections/ IMO - the correction that was issued today was perfect. EVERYTHING IS SET UP PERFECTLY here to reveal a strategic JV with a large MJ company to take advantage of 1/1/18 new law changes for recreational MJ in Cali. AS WELL --- we caught a glimpse of what's to come...this is out west...hmmmm---Very interesting read - healthcare/pharma - blockchain tech Must read to understand why this cross industry appeal for blockchain tech is about to explode and directly benefit pharma, nutraceutical and healthcare industry. https://www.blockchainhealthcare-west.com/?gclid=EAIaIQobChMI4ofQ__yN2AIV2rrACh37hwEpEAAYAiAAEgJ7IPD_BwE NOW CHECK THIS OUT FROM LAST WEEK 12/8/17: A careful review of the SOHM, Inc -- press release actually provides two very key hints as to the ACTUAL OBVIOUS JV direction in Cali they should go. They have the manufacturing facility - they already produce medicinals and neutricuticals ..... They are located in Cali ..... https://www.sohm.com/2017/12/07/sohm-inc-announces-0-5m-purchase-order-for-a-range-of-pharmaceutical-products-in-2018/#.Wilmcgzyo-U.twitter CHINO HILLS, CA—December 7, 2017 – SOHM, Inc. (PINKSHEETS: SHMN) is a globally-known generic pharmaceutical manufacturer, developer and marketer of a wide range of products serving a broad segment of the therapeutics market. SOHM has received a purchase order, with an initial order of more than $0.5 million to supply a range of pharmaceutical products to one of its east coast customers, that will run through the end of 2018. This new purchase order comes from a current customer that has executed purchase orders with SOHM through the end of 2017. A spokesperson for SOHM, Inc., said, “SOHM is very pleased to have received this order from this customer that supplies retail and pharmacy networks all across the United States. This represents an annualized commitment to purchase and distribute 6 products other than SOHM products while providing SOHM a lucrative base to the huge American market for Generic Pharmaceuticals. SOHM’s spokesperson said completion of this order would assure that SOHM achieves its target for higher revenue growth in 2018 compared to previous years. About SOHM, Inc. SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India as well as strategic alliance with US manufacturing facilities. Although SOHM’s generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.